Tci Wealth Advisors, Inc. Kymera Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$14.13 - $42.55 $3,334 - $10,041	236 New	236 $5,000
Q1 2022 Apr 29, 2022	SELL	$35.3 - $64.68 $3,176 - $5,821	-90 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$49.91 - $65.56 $1,447 - $1,901	29 Added 47.54%	90 $6,000
Q3 2021 Oct 29, 2021	BUY	$47.8 - $66.66 $717 - $999	15 Added 32.61%	61 $4,000
Q2 2021 Aug 02, 2021	BUY	$31.08 - $51.95 $1,429 - $2,389	46 New	46 $2,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.